Literature DB >> 25200413

Redefining the primary objective of phase I oncology trials.

Mark J Ratain.   

Abstract

Year:  2014        PMID： 25200413     DOI： 10.1038/nrclinonc.2014.157

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Targeted therapies: redefining the primary objective of phase I oncology trials.

Authors:  Mark J Ratain
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675
  1 in total
  1 in total

1.  Phase I Designs that Allow for Uncertainty in the Attribution of Adverse Events.

Authors:  Alexia Iasonos; John O'Quigley
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2016-11-07       Impact factor: 1.864
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.